&lt;Medizone International Inc> said itexpects the Food and Drug Administration to soon approve thecompany's application to begin limited tests of its potentialtherapy against AIDS using a combination of ozone and oxygen.    The company said that once it receives FDA approval, 20patients with AIDS-related complex will start the treatment atMount Sinai Medical Center in New York.    Dr Joseph Latino, director of research at Medizone said thetherapy, which he likened to a process, uses a combination ofoxygen and ozone injected into a patient's owns blood outsideof the body, and then reinfused back into the body.    "We are guardedly optimistic that this treatment may work,"said Latino, who said the process has been used to treat viralillneses, including AIDS, in Europe with varying degrees ofsuccess.    He said ozone can kill viruses and is used to kill virusesin waste water treatments. He said the treatment should not becompared to inhaling ozone, which is toxic.   Latino said the company is prepared to fund the trial, whichwill cost about 250,000 dlrs.    Reuter&#3;